Does Cenestin (conjugated estrogens) cause side effects?
Estrogens have widespread effects on many tissues in the body. Estrogens cause growth and development of the female sexual organs and maintain female sexual characteristics such as the growth of underarm and pubic hair, body contours, and skeleton. Estrogens also increase secretions from the cervix and growth of the inner lining of the uterus (endometrium).
Menopausal women produce less estrogen which leads to symptoms of hot flashes, vaginal dryness, shrinking in vaginal tissue and painful intercourse. Using conjugated estrogens can help treat such symptoms in menopausal women. Conjugated estrogens can also help in prevention of bone loss in menopausal women.
Common side effects of Cenestin include
- swelling of breasts,
- weight change,
- abdominal pain,
- fluid retention (edema),
- vaginal bleeding, and
- mood disturbances.
Serious side effects of Cenestin include
- an increased risk of heart attacks, stroke, breast cancer, and blood clots in postmenopausal women (50-79 years old),
- increased risk of endometrial cancer, and
- an increased risk of impaired cognition and/or dementia among women over age 65.
Drug interactions of Cenestin include St. John's wort, phenobarbital, carbamazepine, and rifampin, which can accelerate the breakdown of conjugated estrogens, leading to low levels of absorbed drug and reduced effectiveness.
- Grapefruit juice and medications like erythromycin, clarithromycin, ketoconazole, and ritonavir can slow down the breakdown of conjugated estrogens in the liver, leading to increased levels of estrogens and increased estrogen side effects.
Use of Cenestin is not recommended in nursing mothers because conjugated estrogens enter breast milk and may have harmful effects on the newborn. Conjugated estrogens can also affect the quality and quantity of breast milk.
What are the important side effects of Cenestin (conjugated estrogens) ?
There are many side effects of conjugated estrogens. Common side effects of conjugated estrogens are
- swelling of breasts,
- weight change, abdominal pain, anxiety, edema, vaginal bleeding, and mood disturbances.
Estrogens can cause salt (sodium) and water retention (edema). Therefore, patients with heart failure or reduced function of their kidneys who are taking estrogens should be carefully observed for retention of water and its complications.
Blood clots in the legs (deep vein thrombosis or DVT) or lungs (pulmonary embolism) occasionally occur in women taking conjugated estrogens. This potentially serious complication of estrogen therapy is dose-related, that is, it occurs more commonly with higher doses.
Estrogens can promote a build-up of the lining of the uterus (endometrial hyperplasia) and increase the risk of endometrial cancer. (Women who have undergone surgical removal of the uterus – hysterectomy - are not susceptible to endometrial hyperplasia.) The addition of a progestin to estrogen therapy prevents the development of endometrial cancer.
The Women's Health Initiative found that postmenopausal women (50 to 79 years old) taking conjugated estrogens, 0.625 mg daily, in combination with medroxyprogesterone (Provera, Depo-Provera, Depo-Sub Q Provera 104), 2.5 mg daily, for five years, had an increased risk of
There was an increased risk of impaired cognition and/or dementia among women over age 65 treated with either estrogens or estrogens and medroxyprogesterone.
Cenestin (conjugated estrogens) side effects list for healthcare professionals
The following serious adverse reactions are discussed elsewhere in the labeling:
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
In a 12-week clinical trial that included 72 women treated with 0.625 mg and 2 x 0.625 mg Cenestin and 48 women treated with placebo, adverse reactions that occurred at a rate of ≥ 5 percent are summarized in Table 1.
Table 1: Number (%) of Patients with Adverse Reactions with ≥ 5 Percent Occurrence Rate By Body System and Treatment Group
0.625 mg and 2 x 0.625 mg
|Any Adverse Reaction (%)||68 (94)||43 (90)||111 (93)|
|Body As A Whole|
|Abdominal Pain||20 (28)||11 (23)||31 (26)|
|Asthenia||24 (33)||20 (42)||44 (37)|
|Headache||49 (68)||32 (67)||81 (68)|
|Pain||8 (11)||9 (19)||17 (14)|
|Dyspepsia||7 (10)||3 (6)||10 (8)|
|Flatulence||21 (29)||14 (29)||35 (29)|
|Nausea||13 (18)||9 (19)||22 (18)|
|Vomiting||5 (7)||1 (2)||6 (5)|
|Metabolic and Nutritional|
|Peripheral Edema||7 (10)||6 (13)||13 (11)|
|Depression||20 (28)||18 (38)||38 (32)|
|Dizziness||8 (11)||5 (10)||13 (11)|
|Insomnia||30 (42)||23 (48)||53 (44)|
|Leg Cramps||7 (10)||3 (6)||10 (8)|
|Paresthesia||24 (33)||15 (31)||39 (33)|
|Vertigo||12 (17)||12 (25)||24 (20)|
|Urogenital System||21 (29)||7 (15)||28 (23)|
|Breast Pain||4 (6)||3 (6)||7 (6)|
|Dysmenorrhea||10 (14)||3 (6)||13 (11)|
|Metrorrhagia||10 (14)||3 (6)||13 (11)|
|a) Combined results for 0.625 mg and 2 x 0.625 mg Cenestin Tablets|
In a second 12-week clinical trial that included 52 women treated with 0.45 mg Cenestin and 51 women treated with placebo, adverse reactions that occurred at a rate of >5 percent are summarized in Table 2.
Table 2: Number (%) of Patients with a ≥ 5 Percent Occurrence Rate by Body System and Treatment Group
|Body System and Term||Cenestin
|Any Adverse Reaction (%)||40 (75.5%)||39 (76.5%)|
|Body As A Whole||20 (37.7%)||24 (47.1%)|
|Asthenia||6 (11.3%)||7 (13.7%)|
|Headache||6 (11.3%)||8 (15.7%)|
|Infection||1 (1.9%)||6 (11.8%)|
|Pain||6 (11.3%)||1 (2.0%)|
|Pain abdominal||5 (9.4%)||3 (5.9%)|
|Cardiovascular||5 (9.4%)||10 (19.6%)|
|Palpitations||3 (5.7%)||3 (5.9%)|
|Vasodilations||2 (3.8%)||4 (7.8%)|
|Digestive||8 (15.1%)||7 (13.7%)|
|Metabolic and Nutritional||5 (9.4%)||3 (5.9%)|
|Weight increase||3 (5.7%)||2 (3.9%)|
|Musculoskeletal||5 (9.4%)||6 (11.8%)|
|Arthralgia||5 (9.4%)||5 (9.8%)|
|Myalgia||2 (3.8%)||6 (11.8%)|
|Neurological||15 (28.3%)||19 (37.3%)|
|Anxiety||3 (5.7%)||1 (2.0%)|
|Insomnia||3 (5.7%)||5 (9.8%)|
|Nervousness||2 (3.8%)||7 (13.7%)|
|Paresthesia||4 (7.5%)||3 (5.9%)|
|Vertigo||3 (5.7%)||3 (5.9%)|
|Respiratory||10 (18.9%)||6 (11.8%)|
|Rhinitis||3 (5.7%)||2 (3.9%)|
|Urogenital||19 (35.8%)||7 (13.7%)|
|Endometrial thickening||10 (18.9%)||4 (7.8%)|
|Vaginitis||4 (7.5%)||1 (2.0%)|
|If a subject experiences the same event more than once, the first occurrence is tabulated.|
In a 16-week clinical trial that included 36 women treated with 0.3 mg Cenestin and 34 women treated with placebo, adverse reactions that occurred at a rate of ≥5 percent are summarized in Table 3.
Table 3: Number (%) of Patients with Adverse Reactions with ≥ 5 Percent Occurrence Rate By Body System and Treatment Group
|Body System and Term||Cenestin
|Body as a Whole||22 (60)||13 (38)|
|Allergic Reaction||3 (8)||1 (3)|
|Flu Syndrome||3 (8)||1 (3)|
|Injury Accident||2 (5)||1 (3)|
|Back Pain||2 (5)||1 (3)|
|Cyst||2 (5)||0 (0)|
|Asthenia||3 (8)||2 (6)|
|Digestive||10 (27)||8 (24)|
|Nausea||4 (11)||2 (6)|
|Dyspepsia||2 (5)||1 (3)|
|Vomiting||3 (8)||0 (0)|
|Increased Appetite||2 (5)||0 (0)|
|Neurological||7 (19)||7 (21)|
|Dizziness||3 (8)||0 (0)|
|Urogenital||22 (60)||16 (47)|
|Leukorrhea||12 (32)||5 (15)|
|Vaginitis||9 (24)||5 (15)|
|Urinary Incontinence||3 (8)||1 (3)|
|Metrorrhagia||2 (5)||0 (0)|
|Urinary Frequency||2 (5)||0 (0)|
Post Marketing Experience
The following adverse reactions have been identified during post-approval use of Cenestin. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
- Gastrointestinal disorders: abdominal distension, nausea
- Investigations: weight increased
- Metabolism & Nutrition Disorders: fluid retention
- Neoplasms: breast cancer
- Nervous System Disorders: headache, insomnia, somnolence
- Psychiatric Disorder: depression
- Reproductive System and Breast Disorders: breast enlargement, breast pain, breast swelling, breast tenderness
- Skin & Subcutaneous Tissue Disorders: alopecia, pruritus, pruritus generalized, rash pruritic, rash
What drugs interact with Cenestin (conjugated estrogens)?
- No drug-drug interaction studies have been conducted with Cenestin.
- In vitro and in vivo studies have shown that estrogens are metabolized partially by cytochrome P450 3A4 (CYP3A4).
- Therefore, inducers and inhibitors of CYP3A4 may affect estrogen drug metabolism.
- Inducers of CYP3A4 such as St. John’s wort (Hypericum perforatum) preparations, phenobarbital, carbamazepine, and rifampin may reduce plasma concentrations of estrogens, possibly resulting in a decrease in therapeutic effects and/or changes in the uterine bleeding profile.
- Inhibitors of CYP3A4 such as erythromycin, clarithromycin, ketoconazole, itraconazole, ritonavir and grapefruit juice may increase plasma concentrations of estrogens and may result in side effects.
Multimedia: Slideshows, Images & Quizzes
Menopause & Perimenopause: Symptoms, Signs
What is menopause? What are the signs of menopause? What age does menopause start? Learn about menopause and perimenopause...
Women's Health: 10 Tips to Ease Menopause Symptoms
What happens during menopause? At what age do menopause symptoms start? Women in their 40s or 50s may begin to have hot flashes,...
9 Signs of Perimenopause
Perimenopause occurs before menopause as estrogen levels begin to change. This can cause menopause like symptoms such as hot...
Menopause Quiz: Symptoms & Signs
The Menopause Quiz challenges your knowledge about the time in a woman’s life when menstruation ceases. Menopause can bring many...
Related Disease Conditions
What Happens During Menopause?
Menopause is the time in a woman's life when menstrual periods permanently stop, also called the "change of life." Menopause symptoms and signs include hot flashes, night sweats, irregular vaginal bleeding, vaginal dryness, painful intercourse, urinary incontinence, weight gain, and emotional symptoms such as mood swings. Treatment of menopausal symptoms varies, and should be discussed with your physician.
Perimenopause is the time in a woman's life when she is approaching menopause. During this time a woman starts to develop symptoms of declining estrogen levels that may include mood swings, painful sex, night sweats, hot flashes, and weight gain. Every adult woman eventually will experience perimenopause.
Premature menopause is when menopause occurs in a woman before the age of 40. Causes of premature menopause include premature ovarian failure, treatments for cancer and other conditions, surgical removal of the ovaries, or chronic diseases of the pituitary or thyroid gland, or psychiatric disorders. Treatment is directed at menopausal symptoms.
Sex and Menopause
How Long Does Menopause Last?
Some symptoms of menopause such as hot flashes (a sudden feeling of warmth in the upper part of the body) usually last for one to two years. However, they can continue for 10 years or longer.
Sex and Menopause (What to Expect)
Menopause is often associated with a change in sexual functioning. Loss of estrogen, bladder control issues, anxiety, stress, health concerns, medications, and sleep disturbances often result in a decrease in libido. Though there are currently no good drugs for treating sexual problems in women, there are ways to increase intimacy with a partner and treat vaginal dryness.
What Are the 40 Symptoms of Menopause?
Menopause is the end of the reproductive era of a woman’s life that is characterized by drastic changes in her emotional and physical aspects. Studies have identified around 40 signs and symptoms of menopause, but not every woman gets all of them.
Male menopause refers to the decline in testosterone production in men. As men age, they often experience many of the same symptoms that women experience in menopause. Testosterone replacement therapy may relieve some of these symptoms.
15 Things Women Should Know About Menopause
Menopause is a phase in a woman’s life that challenges her physically and emotionally. Many women deal with menopause without any medical treatments, whereas some women with severe symptoms require therapies.
8 Causes of Night Sweats: Menopause and More
Night sweats are episodes of excessive perspiration that happen during sleep. They are often described as soaking or drenching and may require a change of sheets or even clothes. Night sweats can occur during sleep and without physical exertion. They aren’t caused by a heavy blanket or a warm bedroom. Instead, other underlying health issues may be responsible for these episodes of considerable sweating during sleep.
Decreased Response and Pleasure: Sexual Side Effects of Menopause
Menopause marks the end of the reproductive era in a woman’s life. Some women view it positively as periods no longer trouble them and there is no chance of getting pregnant even with unprotected sex. However, as the estrogen and testosterone levels take a plunge during menopause, some women experience the sexual side effects of menopause.
Treatment & Diagnosis
- Male Menopause
- Menopause: Super Nutrition for Menopause
- Menopause and Perimenopause, A Woman's Guide to
- Menopause: The Men's Guide to Understanding It
- Menopause: Making it the Best Years of Your Life
- Menopause: A New Perspective
- Menopause: Change of Life, Change of Diet
- Menopause Made Easy with Carolle Jean-Murat
- Menopause: Taking Charge
- Hormone Therapy After Menopause -- Susan Love, MD
- Menopause FAQs
- Thyroid Disease and Menopause
- The Women's Health Initiative in Perspective: The Last Straw for Estrogen Therapy?
- Menopause: Home Menopause Test Kits, Are They Worth It?
- Hot Flashes: Anxiety Worsens Hot Flashes
- Can Menopause Cause High Cholesterol?
- How Is Menopause Diagnosed After a Hysterectomy?
- How Does Menopause Affect Polycystic Ovarian Syndrome (PCOS)?
- Does Vaginal Moisture Change During Perimenopause?
- Do Soy Isoflavones Treat Menopause Hot Flashes?
- Can You Go Through Menopause at 40?
- Does Perimenopause Cause Mood Swings?
- Does Menopause Cause Pain During Sex?
- Does Menopause Affect Memory?
- Are Night Sweats a Sign of Menopause?
- Can Soy Help Menopause Symptoms?
- Do I Need Birth Control After Menopause?
- Does Menopause Cause High Blood Pressure?
- Do You Get More UTIs During Menopause?
- Can You Still Get Menopause After Hysterectomy?
- Do All Women Get Menopause?
- Male Menopause
- Menopause: 10 Questions To Ask Your Doctor
- Menopause Symptoms
- Ask the Experts - Menopause
- Menopause: Change of Life, Change of Diet
Medications & Supplements
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Professional side effects and drug interactions sections courtesy of the U.S. Food and Drug Administration.